UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000047095 |
|---|---|
| Receipt number | R000053718 |
| Scientific Title | Outcomes of continuous renal replacement therapy: a multicenter retrospective observational study |
| Date of disclosure of the study information | 2022/03/15 |
| Last modified on | 2022/03/06 12:56:37 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Outcomes of continuous renal replacement therapy: a multicenter retrospective observational study
Acronym
Outcomes of continuous renal replacement therapy: a multicenter retrospective observational study
Scientific Title
Outcomes of continuous renal replacement therapy: a multicenter retrospective observational study
Scientific Title:Acronym
Outcomes of continuous renal replacement therapy: a multicenter retrospective observational study
Region
| Japan |
Condition
Condition
Patients requiring continuous renal replacement therapy
Classification by specialty
| Intensive care medicine |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To evaluate the outcomes of continuous renal replacement therapy
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Temporal changes of blood electrolyte concentrations during continuous renal replacement therapy
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
1) Patients treated by continuous renal replacement therapy from March 2021 to March 2022
2) Patients with more than one daily test 24 hours after treatment initiation
3) Patients treated with SUBPACK-Bi or Sublood-BSG
Key exclusion criteria
Patients who refuse to participate in this study based on the optout
Target sample size
1000
Research contact person
Name of lead principal investigator
| 1st name | Kent |
| Middle name | |
| Last name | Doi |
Organization
The Univerity of Tokyo
Division name
Department of Emergency and Critical Care Medicine
Zip code
113-8654
Address
7-3-1, Hongo, Bunkyo-ku, Tokyo
TEL
03-3812-2111
kentdoi@m.u-tokyo.ac.jp
Public contact
Name of contact person
| 1st name | Yutaro |
| Middle name | |
| Last name | Inoue |
Organization
The Univerity of Tokyo
Division name
Department of Emergency and Critical Care Medicine
Zip code
113-8654
Address
7-3-1, Hongo, Bunkyo-ku, Tokyo
TEL
03-3812-2111
Homepage URL
inouey-eme@h.u-tokyo.ac.jp
Sponsor or person
Institute
the University of Tokyo
Institute
Department
Personal name
Funding Source
Organization
Nipro corporation
Organization
Division
Category of Funding Organization
Profit organization
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Office for Human Research Studies Graduate School of Medicine and Faculty of Medicine, The University of Tokyo
Address
7-3-1, Hongo, Bunkyo-ku, Tokyo
Tel
03-3812-2111
ethics@m.u-tokyo.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2022 | Year | 03 | Month | 15 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2022 | Year | 02 | Month | 14 | Day |
Date of IRB
Anticipated trial start date
| 2022 | Year | 03 | Month | 15 | Day |
Last follow-up date
| 2022 | Year | 06 | Month | 15 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Others
Management information
Registered date
| 2022 | Year | 03 | Month | 06 | Day |
Last modified on
| 2022 | Year | 03 | Month | 06 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053718
